ELOX
Eloxx Pharmaceuticals Inc

2,536
Loading...
Loading...
Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid-modulating drug candidates. The firm focuses on the the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. Its lead product candidate is ELX-02, a small molecule drug designed to restore production of full-length functional proteins. It operates through the United States and Israel geographical segments. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Eloxx Pharmaceuticals Inc?
What is the 52-week high for Eloxx Pharmaceuticals Inc?
What is the 52-week low for Eloxx Pharmaceuticals Inc?
What is Eloxx Pharmaceuticals Inc stock price today?
What was Eloxx Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Eloxx Pharmaceuticals Inc?
What is the Price-to-Book ratio of Eloxx Pharmaceuticals Inc?
What is Eloxx Pharmaceuticals Inc's EBITDA?
What is the 50-day moving average of Eloxx Pharmaceuticals Inc?

Latest ELOX News

View
No ELOX news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.